Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Irene Oi-lin Ng

The University of Hong Kong

Hong Kong

Research Interests

Explore related searches

Professors in Cell Biology

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (3)

Xin Wei Wang

Acting Chief

National Cancer Institute

UNITED STATES

View details

Young Nyun Park

Yonsei University College of Medicine

SOUTH KOREA

View details

Jason Mills

Chair and professor

Penn State College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Irene Oi-lin Ng

Research Interests

Explore related searches

Articles (20)

Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma

BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinoma

The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease

Immunotherapy in HCC: aetiology matters

Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma

STEA: Histologically Validated and Reference-Independent Major Cell-Type Annotation for Spatial Transcriptomics Reveals Relevant Cellular Organization and Architecture of Tumor Microenvironment

Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumors

Repurposing resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression

The<i> Lancet</i> Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment

Cancer stem cells in hepatocellular carcinoma: platforms, updates, challenges and future perspectives

Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification

Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis

Spatiotemporal dynamics of T cells in peripheral blood and tumor underlying differential responses to neoadjuvant PD-1 blockade in hepatocellular carcinoma

Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinoma

Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy

Secreted lumican from the tumor microenvironment potentiates HCC stemness and progression

MASLD/MASH—New mechanisms and treatments

Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer

GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC

Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response

Collaborators (3)

Xin Wei Wang

Young Nyun Park

Jason Mills

Make your next move.